Crew Capital Management, Ltd. Bristol Myers Squibb CO Transaction History

Crew Capital Management, Ltd.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$48.48 - $57.85 $19,198 - $22,908	-396 Reduced 7.08%	5,195 $266,000
Q3 2023 Nov 02, 2023	SELL	$57.89 - $64.73 $96,792 - $108,228	-1,672 Reduced 23.02%	5,591 $324,000
Q2 2023 Jul 20, 2023	SELL	$63.71 - $70.74 $119,137 - $132,283	-1,870 Reduced 20.48%	7,263 $464,000
Q1 2023 Apr 17, 2023	SELL	$65.71 - $74.53 $45,996 - $52,171	-700 Reduced 7.12%	9,133 $633,000
Q4 2022 Jan 18, 2023	SELL	$68.48 - $81.09 $30,816 - $36,490	-450 Reduced 4.38%	9,833 $0
Q3 2022 Oct 20, 2022	SELL	$0.13 - $76.84 $32 - $19,210	-250 Reduced 2.37%	10,283 $731,000
Q2 2022 Jul 28, 2022	SELL	$72.62 - $79.98 $10,893 - $11,997	-150 Reduced 1.4%	10,533 $811,000
Q1 2022 Apr 28, 2022	SELL	$61.48 - $73.72 $12,296 - $14,744	-200 Reduced 1.84%	10,683 $780,000
Q4 2021 Feb 07, 2022	SELL	$53.63 - $62.52 $42,904 - $50,016	-800 Reduced 6.85%	10,883 $679,000
Q3 2021 Oct 18, 2021	SELL	$59.17 - $69.31 $14,792 - $17,327	-250 Reduced 2.1%	11,683 $691,000
Q2 2021 Aug 09, 2021	SELL	$61.91 - $67.42 $6,191 - $6,742	-100 Reduced 0.83%	11,933 $797,000
Q1 2021 Apr 30, 2021	BUY	$59.34 - $66.74 $714,038 - $803,082	12,033 New	12,033 $760,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Crew Capital Management, Ltd., based on Form 13F filings with the SEC.

Stay updated on Crew Capital Management, Ltd. with notifications on news.